COVID-19 Outbreak Response Agreement (ver 3.1)Covid-19 Outbreak Response Agreement • May 10th, 2021 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • England and Wales
THIS AGREEMENT (the “Agreement”) is between Awardee and the Coalition for Epidemic Preparedness Innovations (“CEPI”) and is effective as of the date of the last signature, below (the “Effective Date”). Each party to this Agreement may be referred to individually as a “Party” and together as the “Parties.” This Agreement sets out the terms and conditions governing the performance and funding of the Project (as defined herein). It also reflects the Parties’ mutual commitment to develop a safe and effective vaccine against SARS-CoV-2, to test and obtain regulatory approval for the vaccine as rapidly as possible, consistent with patient safety and achieving vaccine quality, and to ensure the manufacture and distribution of sufficient quantities of the vaccine to meet global demand at affordable prices in the country of use. As a condition of this funding award, the Parties enter into this Agreement by having their authorised representatives sign below.
AMENDING AGREEMENTAmending Agreement • May 10th, 2021 • VBI Vaccines Inc/Bc • Pharmaceutical preparations
This Amending Agreement (the “Agreement”), effective as of April 8, 2021 (the “Effective Date”), is by and between VBI VACCINES INC., a company organized under the laws of the Province of British Columbia, Canada (“VBI”), and having a principal place of business at 310 Hunt Club Road, Suite 201, Ottawa ON K1V 1C1, and Brii Biosciences Limited, an exempted company organized under the laws of the Cayman Islands (“Brii Bio”), having its registered office at Vistra (Cayman) Limited, PO Box 3119, Grand Pavilion Hibiscus Way, 802 West Bay Road Grand Cayman KYI- 1205. VBI and Brii Bio are sometimes referred to as a “Party” and are collectively referred to as the “Parties”. Terms having capital letters which are not defined herein shall have the meanings given thereto in the Collaboration Agreement (as defined below).
AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • May 10th, 2021 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • Ontario
This Amendment to Consulting Agreement (the “Amendment”), effective as of July 1, 2020 (the “Effective Date”), is by and between Variation Biotechnologies Inc., a corporation incorporated pursuant to the laws of Canada (the “Company”) having an address of 310 Hunt Club Road East, Ottawa, Ontario K1V 1C1 and F. Diaz-Mitoma Professional Corporation (Ontario corporation number 002356634) having an address of 210 Barrow Crescent, Kanata, Ontario K2L 2C7 (“Consultant”). The Consultant and Company are sometimes referred to as a “Party” and are collectively referred to as the “Parties”.
